Загрузка...
Recent advances in personalized lung cancer medicine
The identification of molecular subtypes of non-small-cell lung cancer has transformed the clinical management of this disease. This is best exemplified by the clinical success of targeting the EGFR or ALK with tyrosine kinase inhibitors in the front-line setting. Our ability to further improve pati...
Сохранить в:
| Опубликовано в: : | Per Med |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4263209/ https://ncbi.nlm.nih.gov/pubmed/25506379 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|